Results 41 to 50 of about 13,763,316 (290)

The Impact of Tenapanor on Body Composition and Blood Pressure in Peritoneal Dialysis Patients: A Pilot Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Instruction Tenapanor potentially affects fluid volume and blood pressure. This study explored its effects on these parameters in patients undergoing peritoneal dialysis (PD). Methods We conducted a single‐arm, prospective observational study that enrolled 10 patients on PD with hyperphosphatemia who were newly initiated on tenapanor.
Shun Yoshida   +11 more
wiley   +1 more source

GRADE confidence assessments of indirect estimates per pairwise treatment comparison for all-cause mortality.

open access: yes, 2016
GRADE confidence assessments of indirect estimates per pairwise treatment comparison for all-cause mortality.
Reem Al-Khalifah (3215421)   +10 more
core   +1 more source

Methodological considerations for novel approaches to covariate‐adjusted indirect treatment comparisons

open access: yesResearch Synthesis Methods, 2023
AbstractWe examine four important considerations in the development of covariate adjustment methodologies for indirect treatment comparisons. First, we consider potential advantages of weighting versus outcome modeling, placing focus on bias‐robustness. Second, we outline why model‐based extrapolation may be required and useful, in the specific context
Antonio Remiro‐Azócar   +2 more
openaire   +4 more sources

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

open access: yesFEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens   +8 more
wiley   +1 more source

Baseline characteristics of the studies included in the indirect treatment comparison for cabazitaxel, abiraterone acetate and enzalutamide.

open access: yes, 2018
Baseline characteristics of the studies included in the indirect treatment comparison for cabazitaxel, abiraterone acetate and enzalutamide.
Jackie Vanderpuye-Orgle (5089457)   +6 more
core   +1 more source

An investigation of the impact of using different methods for network meta-analysis: a protocol for an empirical evaluation

open access: yesSystematic Reviews, 2017
Background Network meta-analysis, a method to synthesise evidence from multiple treatments, has increased in popularity in the past decade. Two broad approaches are available to synthesise data across networks, namely, arm- and contrast-synthesis models,
Amalia (Emily) Karahalios   +7 more
doaj   +1 more source

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

open access: yesRheumatology and Therapy, 2023
Introduction Biologic disease-modifying anti-rheumatic drugs (bDMARDs), including certolizumab pegol (CZP), are effective treatment options for the management of non-radiographic spondyloarthritis (nr-axSpA). In the absence of head-to-head comparisons in
Nurullah Akkoç   +9 more
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

Metastatic renal cell cancer treatments: An indirect comparison meta-analysis [PDF]

open access: yesBMC Cancer, 2009
Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved progression-free survival (PFS). We aimed to determine the relative effectiveness of new therapies in this field.We conducted comprehensive searches of 11 electronic databases from
Mills, Edward J   +4 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy